PURPOSE: Recent studies suggest a potential application for digoxin in the prevention and/or treatment of prostate cancer. However, the effect of digoxin on androgen receptor (AR)-positive prostate tumor in vivo is not clear. This study is designed to determine if digoxin can inhibit AR-positive xenograft prostate tumors. MATERIALS AND METHODS: Athymic male nude mice were utilized to establish subcutaneous C4-2 castration-resistant prostate tumors. The animals were castrated and then treated with daily intraperitoneal (i.p.) injection of digoxin at 2 mg/kg along with vehicle controls for 7 consecutive days. Tumor growth was determined by measuring tumor volume changes, blood vessel density by immunostaining of CD31, and cell proliferation by BrdU labeling. The expression of HIF-1α in C4-2 tumors was measured by Western blot and real-time RT-PCR. RESULTS: Digoxin inhibited blood vessel density about fourfold and down-regulated HIF-1α expression at both mRNA and protein levels. However, digoxin did not inhibit C4-2 tumor growth. CONCLUSIONS: Digoxin is a potent inhibitor of HIF-1α signaling pathway and blood vessel formation in C4-2 castration-resistant prostate tumors.
PURPOSE: Recent studies suggest a potential application for digoxin in the prevention and/or treatment of prostate cancer. However, the effect of digoxin on androgen receptor (AR)-positive prostate tumor in vivo is not clear. This study is designed to determine if digoxin can inhibit AR-positive xenograft prostate tumors. MATERIALS AND METHODS: Athymic male nude mice were utilized to establish subcutaneous C4-2 castration-resistant prostate tumors. The animals were castrated and then treated with daily intraperitoneal (i.p.) injection of digoxin at 2 mg/kg along with vehicle controls for 7 consecutive days. Tumor growth was determined by measuring tumor volume changes, blood vessel density by immunostaining of CD31, and cell proliferation by BrdU labeling. The expression of HIF-1α in C4-2 tumors was measured by Western blot and real-time RT-PCR. RESULTS:Digoxin inhibited blood vessel density about fourfold and down-regulated HIF-1α expression at both mRNA and protein levels. However, digoxin did not inhibit C4-2 tumor growth. CONCLUSIONS:Digoxin is a potent inhibitor of HIF-1α signaling pathway and blood vessel formation in C4-2 castration-resistant prostate tumors.
Authors: Alexandros Lekas; Andreas C Lazaris; Charalampos Deliveliotis; Michail Chrisofos; Christina Zoubouli; Dimitrios Lapas; Thomas Papathomas; Ioannis Fokitis; Lydia Nakopoulou Journal: Anticancer Res Date: 2006 Jul-Aug Impact factor: 2.480
Authors: G N Thalmann; P E Anezinis; S M Chang; H E Zhau; E E Kim; V L Hopwood; S Pathak; A C von Eschenbach; L W Chung Journal: Cancer Res Date: 1994-05-15 Impact factor: 12.701
Authors: K Maeda; Y S Chung; S Takatsuka; Y Ogawa; N Onoda; T Sawada; Y Kato; A Nitta; Y Arimoto; Y Kondo Journal: Br J Cancer Date: 1995-08 Impact factor: 7.640
Authors: Thomas Crezee; Marika H Tesselaar; James Nagarajah; Willem E Corver; Johannes Morreau; Catrin Pritchard; Shioko Kimura; Josephina G Kuiper; Ilse van Engen-van Grunsven; Jan W A Smit; Romana T Netea-Maier; Theo S Plantinga Journal: Cell Oncol (Dordr) Date: 2021-02-03 Impact factor: 6.730
Authors: José Manuel Calderón-Montaño; Estefanía Burgos-Morón; Manuel Luis Orta; Dolores Maldonado-Navas; Irene García-Domínguez; Miguel López-Lázaro Journal: Biomed Res Int Date: 2014-05-08 Impact factor: 3.411